Residential Collegefalse
Status已發表Published
Reply to Chan et al.
Liyang Zhao1; Yusi Li1; Wenjuan Yi2; Kuo Yan3; Chao Yang4; Sridhar Radhakrishnan5; Rui Li6; Ruirong Tan7; Gang Fan8; Mengyuan Dai9; Miao Liu10; Ning‐Yi Shao1,11
2022-11-04
Source PublicationJournal of Medical Virology
ISSN0146-6615
Volume95Issue:1Pages:e28283
Abstract

We agree that smoking might be a risk factor for the severity of COVID-19, but in our previous study, smoking was not so robust compared with our conclusion. Also, we strongly agreed that COVID-19 patients with diabetes or other chronic diseases might worsen the situation of the disease. But these factors were out of the scope of our study and we had published other research on this topic related to diabetes. Because of the limited sample size and original medical records, our study could not cover many factors. But we wish our study will be a useful and meaningful pilot study for future studies.

DOI10.1002/jmv.28283
URLView the original
Indexed BySCIE
Language英語English
WOS Research AreaVirology
WOS SubjectVirology
WOS IDWOS:000911465200203
PublisherWILEY111 RIVER ST, HOBOKEN 07030-5774, NJ
Scopus ID2-s2.0-85145910605
Fulltext Access
Citation statistics
Document TypeJournal article
CollectionMinistry of Education Frontiers Science Center for Precision Oncology, University of Macau
Faculty of Health Sciences
DEPARTMENT OF BIOMEDICAL SCIENCES
Corresponding AuthorMengyuan Dai; Miao Liu; Ning‐Yi Shao
Affiliation1.Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Macao
2.Department of Dermatology, Zhongnan Hospital of Wuhan University, Wuhan, China
3.Institute of Cell and Neurobiology, Charité Medical University, Berlin, Germany
4.Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, United States
5.Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
6.Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
7.Translational Chinese Medicine Key Laboratory of Sichuan Province, Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu, China
8.Department of Urology, Huazhong University of Science and Technology Union Shenzhen Hospital, The 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China
9.Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China
10.Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, United States
11.MoE Frontiers Science Center for Precision Oncology, Faculty of Health Sciences, University of Macau, Macao
First Author AffilicationFaculty of Health Sciences
Corresponding Author AffilicationFaculty of Health Sciences
Recommended Citation
GB/T 7714
Liyang Zhao,Yusi Li,Wenjuan Yi,et al. Reply to Chan et al.[J]. Journal of Medical Virology, 2022, 95(1), e28283.
APA Liyang Zhao., Yusi Li., Wenjuan Yi., Kuo Yan., Chao Yang., Sridhar Radhakrishnan., Rui Li., Ruirong Tan., Gang Fan., Mengyuan Dai., Miao Liu., & Ning‐Yi Shao (2022). Reply to Chan et al.. Journal of Medical Virology, 95(1), e28283.
MLA Liyang Zhao,et al."Reply to Chan et al.".Journal of Medical Virology 95.1(2022):e28283.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Liyang Zhao]'s Articles
[Yusi Li]'s Articles
[Wenjuan Yi]'s Articles
Baidu academic
Similar articles in Baidu academic
[Liyang Zhao]'s Articles
[Yusi Li]'s Articles
[Wenjuan Yi]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Liyang Zhao]'s Articles
[Yusi Li]'s Articles
[Wenjuan Yi]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.